Pulse Biosciences, Inc. (PLSE) Tops Q1 EPS by 3c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q1 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $400 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Zuckerberg Directed Meta To Create Prediction Markets App - NYT